Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-19T05:29:33.123Z Has data issue: false hasContentIssue false
  • English
  • Français

Intensified Infection Control Measures to Minimize the Spread of Colistin-Resistant Acinetobacter baumannii

Published online by Cambridge University Press:  02 January 2015

Anucha Apisaranthanarak ,
Sassinuch Rujanavech ,
Pornpong Luxamesathaporn  and
Linda M. Mundy
Anucha Apisaranthanarak*
Affiliation:
Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Pathumthani, Thailand
Sassinuch Rujanavech
Affiliation:
Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Pathumthani, Thailand
Pornpong Luxamesathaporn
Affiliation:
Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Pathumthani, Thailand
Linda M. Mundy
Affiliation:
LM Mundy, Bryn Mawr, Pennsylvania
*
Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Pathumthani, Thailand12120 ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 34 , Issue 4 , April 2013 , pp. 445 - 447
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2013

References

1.Peleg, AY, Seifert, H, Paterson, DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538–582.Google Scholar
2.Apisarnthanarak, A, Hsu, LY, Khawcharoenporn, T, Mundy, LM. Carbapenem-resistant gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings? Expert Rev Anti Infect Ther 2013;11:147–157.Google Scholar
3.Biswas, S, Brunel, JM, Dubus, JC, Reynaud-Gaubert, M, Rolain, JM. Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti Infect Ther 2012;10:917–934.Google Scholar
4.Apisarnthanarak, A, Warren, DK, Fraser, VJ. Creating a cohort area to limit transmission of pandrug-resistant Acinetobacter baumannii in a Thai tertiary care center. Clin Infect Dis 2009;48:1487–1488.Google Scholar
5.Apisarnthanarak, A, Kiratisin, P, Khawcharoenporn, T, Warren, DK. Using an intensified infection prevention intervention to control carbapenemase-producing Enterobacteriaceae at a Thai center. Infect Control Hosp Epidemiol 2012;33:960–961.Google Scholar
6.Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(10 suppl 2):S165–S193.Google Scholar
7.Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256–260.Google Scholar